NervGen Pharma Corp. (NGEN)
1.72
-0.06
(-3.37%)
USD |
NASDAQ |
Jul 22, 13:01
NervGen Pharma Price : 1.72 for July 22, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 21, 2026 | 1.75 | 1.84 | 1.74 | 1.78 | 682371.0 |
| Jul 20, 2026 | 1.70 | 1.80 | 1.695 | 1.73 | 600320.0 |
| Jul 17, 2026 | 1.65 | 1.70 | 1.59 | 1.67 | 858349.0 |
| Jul 16, 2026 | 1.69 | 1.75 | 1.61 | 1.67 | 1.474M |
| Jul 15, 2026 | 1.76 | 1.79 | 1.68 | 1.69 | 1.323M |
| Jul 14, 2026 | 1.95 | 1.995 | 1.73 | 1.74 | 1.305M |
| Jul 13, 2026 | 2.06 | 2.06 | 1.90 | 1.93 | 1.128M |
| Jul 10, 2026 | 1.92 | 1.94 | 1.80 | 1.88 | 787464.0 |
| Jul 09, 2026 | 1.90 | 1.959 | 1.85 | 1.86 | 779232.0 |
| Jul 08, 2026 | 2.02 | 2.02 | 1.84 | 1.85 | 1.467M |
| Jul 07, 2026 | 2.10 | 2.10 | 1.99 | 2.01 | 300634.0 |
| Jul 06, 2026 | 2.10 | 2.16 | 2.08 | 2.11 | 424605.0 |
| Jul 02, 2026 | 2.11 | 2.22 | 2.09 | 2.12 | 605204.0 |
| Jul 01, 2026 | 2.06 | 2.16 | 2.05 | 2.09 | 607623.0 |
| Jun 30, 2026 | 1.97 | 2.10 | 1.91 | 2.06 | 929134.0 |
| Jun 29, 2026 | 1.91 | 2.005 | 1.90 | 1.96 | 806129.0 |
| Jun 26, 2026 | 1.87 | 1.95 | 1.85 | 1.87 | 1.081M |
| Jun 25, 2026 | 2.00 | 2.07 | 1.88 | 1.91 | 923562.0 |
| Jun 24, 2026 | 2.07 | 2.15 | 1.975 | 1.99 | 567317.0 |
| Jun 23, 2026 | 2.10 | 2.20 | 2.05 | 2.06 | 807366.0 |
| Jun 22, 2026 | 2.21 | 2.345 | 2.14 | 2.14 | 670348.0 |
| Jun 18, 2026 | 2.20 | 2.31 | 2.09 | 2.20 | 1.487M |
| Jun 17, 2026 | 1.95 | 2.20 | 1.92 | 2.19 | 1.207M |
| Jun 16, 2026 | 1.87 | 2.00 | 1.77 | 2.00 | 796997.0 |
| Jun 15, 2026 | 1.95 | 1.99 | 1.825 | 1.86 | 838626.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| InMed Pharmaceuticals, Inc. | 1.75 |
| Milestone Pharmaceuticals, Inc. | 1.205 |
| Clearmind Medicine, Inc. | 1.68 |
| Pharmagreen Biotech, Inc. | 0.0009 |
| Lexaria Bioscience Corp. | 0.5799 |
Price Related Metrics
| PEG Ratio | -0.0840 |
| Price to Book Value | 35.08 |
| Earnings Yield | -23.20% |
| Market Cap | 139.30M |
| PEGY Ratio | -0.0840 |